Biotech Firm Adaptimmune Attracts $104 Million Investment by WILLIAM ALDEN

By WILLIAM ALDEN

New Enterprise Associates, a venture capital firm, led the financing round in Adaptimmune Limited, which is developing a treatment for cancer.

Published: September 24, 2014 at 4:00AM

from NYT Business Day http://ift.tt/1qvSxSH

from WordPress http://ift.tt/1B8LLsl

via Hadi Aboukhater